Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations - PubMed

• PMID: 25946288
• DOI: 10.1056/NEJMms1502493

Free article

Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations

Lisa Rosenbaum. N Engl J Med. 2015.

Free article

Comment in

• Conflicts of Interest.

  Rosenbaum L. Rosenbaum L. N Engl J Med. 2015 Aug 20;373(8):779-80. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287861 No abstract available.

• Conflicts of Interest.

  Abramson J, Redberg R. Abramson J, et al. N Engl J Med. 2015 Aug 20;373(8):778. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287862 No abstract available.

• Conflicts of Interest.

  Roper N. Roper N. N Engl J Med. 2015 Aug 20;373(8):778. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287863 No abstract available.

• Conflicts of Interest.

  Fleischman W, Newman DH. Fleischman W, et al. N Engl J Med. 2015 Aug 20;373(8):778-9. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287864 No abstract available.

• Conflicts of Interest.

  Strandberg TE. Strandberg TE. N Engl J Med. 2015 Aug 20;373(8):779. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287865 No abstract available.

Similar articles

• Conflicts of Interest.

  Strandberg TE. Strandberg TE. N Engl J Med. 2015 Aug 20;373(8):779. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287865 No abstract available.

• Conflicts of Interest.

  Fleischman W, Newman DH. Fleischman W, et al. N Engl J Med. 2015 Aug 20;373(8):778-9. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287864 No abstract available.

• Conflicts of Interest.

  Roper N. Roper N. N Engl J Med. 2015 Aug 20;373(8):778. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287863 No abstract available.

• Conflict of interest in the physician interface with the biomedical industry.

  Minnigan H, Chisholm CD. Minnigan H, et al. Emerg Med Clin North Am. 2006 Aug;24(3):671-85. doi: 10.1016/j.emc.2006.05.008. Emerg Med Clin North Am. 2006. PMID: 16877136 Review.

• Review article: gastroenterology and the pharmaceutical industry.

  Rakatansky H. Rakatansky H. Aliment Pharmacol Ther. 2002 Nov;16(11):1859-66. doi: 10.1046/j.1365-2036.2002.01362.x. Aliment Pharmacol Ther. 2002. PMID: 12390094 Review.

Cited by

• Mining Open Payments Data: Analysis of Industry Payments to Thoracic Surgeons From 2014-2016.

  Na X, Guo H, Zhang Y, Shen L, Wu S, Li J. Na X, et al. J Med Internet Res. 2018 Nov 30;20(11):e11655. doi: 10.2196/11655. J Med Internet Res. 2018. PMID: 30504119 Free PMC article.

• Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry.

  Andreatos N, Zacharioudakis IM, Zervou FN, Muhammed M, Mylonakis E. Andreatos N, et al. Medicine (Baltimore). 2017 Jan;96(2):e5711. doi: 10.1097/MD.0000000000005711. Medicine (Baltimore). 2017. PMID: 28079800 Free PMC article.

• Fighting about conflict of interest: where should the balance lie?

  Misselbrook D. Misselbrook D. Br J Gen Pract. 2016 Feb;66(643):66-7. doi: 10.3399/bjgp16X683569. Br J Gen Pract. 2016. PMID: 26823246 Free PMC article. No abstract available.

• When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples.

  Scheim DE, Aldous C, Osimani B, Fordham EJ, Hoy WE. Scheim DE, et al. J Clin Med. 2023 May 23;12(11):3625. doi: 10.3390/jcm12113625. J Clin Med. 2023. PMID: 37297820 Free PMC article.

• Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program.

  Modi PK, Farber NJ, Zavaski ME, Jang TL, Singer EA, Chang SL. Modi PK, et al. Urol Pract. 2017 Jul;4(4):342-347. doi: 10.1016/j.urpr.2016.07.008. Urol Pract. 2017. PMID: 28775998 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.